Catalysts for Rising Pharma Holdings Inc

Riluzole Oral Suspension shortage — EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)

DOXYCYCLINE HYCLATE — FDA approval

DOXYCYCLINE HYCLATE — FDA approval

DOXYCYCLINE HYCLATE — FDA approval

DOXYCYCLINE HYCLATE — FDA approval

MESNA — FDA approval

CLINDAMYCIN PHOSPHATE — FDA approval

ONDANSETRON HYDROCHLORIDE — FDA approval

GLYCOPYRROLATE — FDA approval

DIGOXIN — FDA approval

GABAPENTIN — FDA approval

BUDESONIDE — FDA approval

DIVALPROEX SODIUM — FDA approval

DIVALPROEX SODIUM — FDA approval

DIVALPROEX SODIUM — FDA approval

ANAGRELIDE HYDROCHLORIDE — FDA approval

TOREMIFENE CITRATE — FDA approval

MECLIZINE HYDROCHLORIDE — FDA approval

LORAZEPAM — FDA approval

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

BUTORPHANOL TARTRATE — FDA approval

SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval

NALBUPHINE HYDROCHLORIDE — FDA approval

SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approval

NALBUPHINE HYDROCHLORIDE — FDA approval

ALFENTA (ALFENTANIL HYDROCHLORIDE) — FDA approval

TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval

EPLERENONE — FDA approval

DICHLORPHENAMIDE — FDA approval

NALBUPHINE HYDROCHLORIDE — FDA approval